Literature DB >> 35882696

ASO Author Reflections: Novel Treatment De-escalation Strategies for Retropharyngeal Metastatic Disease in Head and Neck and Thyroid Cancer with Transoral Robotic Surgery (TORS).

George Garas1,2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35882696     DOI： 10.1245/s10434-022-12297-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  5 in total

Review 1.  Robotics in otorhinolaryngology - head and neck surgery.

Authors:  George Garas; Neil Tolley
Journal:  Ann R Coll Surg Engl       Date:  2018-09       Impact factor: 1.891

2.  Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.

Authors:  Julian Biau; Michel Lapeyre; Idriss Troussier; Wilfried Budach; Jordi Giralt; Cai Grau; Joanna Kazmierska; Johannes A Langendijk; Mahmut Ozsahin; Brian O'Sullivan; Jean Bourhis; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2019-01-30       Impact factor: 6.280

3.  ASO Visual Abstract: Novel Strategies for Managing Retropharyngeal Lymph Node Metastases in Head and Neck and Thyroid Cancer with TransOral Robotic Surgery (TORS).

Authors:  George Garas; Nick J Roland; Jeffrey Lancaster; Matthew Zammit; Victoria A Manon; Katharine Davies; Terry M Jones; Mriganka De; Floyd C Holsinger; Robin J D Prestwich; Jason C Fleming
Journal:  Ann Surg Oncol       Date:  2022-11       Impact factor: 4.339

4.  Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.

Authors:  Neil D Gross; Todd W Ellingson; Mark K Wax; James I Cohen; Peter E Andersen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-02

Review 5.  De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies.

Authors:  Hisham Mehanna; Danny Rischin; Stuart J Wong; Vincent Gregoire; Robert Ferris; John Waldron; Quynh-Thu Le; Martin Forster; Maura Gillison; Sarbani Laskar; Makoto Tahara; Amanda Psyrri; Jan Vermorken; Sandro Porceddu
Journal:  J Clin Oncol       Date:  2020-06-04       Impact factor: 44.544
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.